U.S. Capital Markets Stock News

Taboola.com (TBLA) closed out FY 2025 with Q4 revenue of US$522.3 million and basic EPS of US$0.17, alongside Q4 2024 figures of US$491.0 million in revenue and basic EPS of US$0.10. Over the latest reported periods, revenue has moved from US$433.0 million in Q3 2024 to US$496.8 million in Q3 2025, while basic EPS shifted from a loss of US$0.02 to a profit of US$0.02. This highlights a story in which improving profitability and tighter margins are front and center for investors assessing this...

In the past quarter, Gladstone Land Corporation reported fourth-quarter 2025 sales of US$41.45 million and net income of US$4.21 million, alongside full-year 2025 revenue of US$88.34 million and net income of US$13.53 million. The sharp year-over-year improvement in quarterly sales and earnings contrasts with softer full-year sales, highlighting how recent operational performance may be shifting for this farmland-focused REIT. Next, we’ll consider how this strong quarterly earnings growth,...

Keurig Dr Pepper (KDP) has wrapped up FY 2025 with fourth quarter revenue of US$4.5 billion and basic EPS of US$0.26, setting the tone for how investors assess the full year. The company has seen quarterly revenue move from US$4.1 billion in Q4 2024 to US$4.5 billion in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 to EPS of US$0.26 over the same period, against a trailing twelve month EPS of US$1.53. With trailing net margin at 12.5% and earnings growth highlighted over the...

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

Analysts are flagging anticipated revenue declines for Fortive, citing softer demand and slower organic growth expectations. This shift in sentiment follows previously solid quarterly results and points to a possible inflection in the company’s operational outlook. The change comes as investors reassess Fortive’s near term growth profile beyond recent share price moves. For investors watching Fortive, ticker NYSE:FTV, the backdrop is a mix of steady share performance and growing questions...

Array Digital Infrastructure (NYSE:AD) has completed a transformation by selling its wireless operations and related spectrum assets. The company transferred spectrum holdings to major carriers, including T-Mobile and AT&T, and repositioned itself as a focused tower operator. Array Digital Infrastructure secured new long term Master License Agreements with top telecom companies for tower usage. The company distributed special dividends and outlined plans to invest further in its...

Bank of Hawaii (NYSE:BOH) has announced that its CEO plans to retire at the end of March 2026. A board member recently executed a substantial sale of Bank of Hawaii shares. These leadership and ownership changes come as the stock last closed at $76.83. For investors watching Bank of Hawaii, the combination of a planned CEO retirement and a large board member share sale puts the focus squarely on governance and continuity. NYSE:BOH last closed at $76.83, with the stock showing returns of...

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...

Oncolytics Biotech (ONCY) has attracted fresh attention after a recent move in its share price, with the stock closing at US$1.13 and showing mixed return patterns across the past year and over multiple years. See our latest analysis for Oncolytics Biotech. The recent 6.6% 1 day share price return and 10.8% 7 day share price return suggest short term momentum is building around Oncolytics Biotech, even as the 58.3% 1 year total shareholder return contrasts with weaker 3 and 5 year total...

Preferred Bank reclassified a sizable loan relationship from substandard to nonaccrual status following ongoing legal complications involving the borrower’s principals. The borrower is facing complex lawsuits that have contributed to cash flow pressures and payment issues on the loan. Management has indicated that, based on current expectations, the ultimate resolution of this credit is not expected to significantly affect 2026 earnings. For you as an investor following NasdaqGS:PFBC, this...

The Morning Bull - US Market Morning Update Wednesday, Feb, 25 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.1% and Nasdaq-100 futures ahead by roughly 0.2%, as investors weigh stronger hiring against easier borrowing costs. Fresh figures from ADP show private employers adding around 12,750 jobs a week over the past month, the fastest pace since late November, which signals companies are still hiring and paychecks are still flowing...

If you are wondering whether Sinclair's current share price fairly reflects its underlying worth, you are not alone. Many investors are asking the same question as the stock trades around US$14.06. The share price has seen mixed returns, with a 6.0% decline over the last 7 days and a 6.6% decline over 30 days, along with a 2.9% gain over 1 year and a 6.3% gain over 3 years, while the 5 year return sits at a 46.3% decline. Recent headlines around Sinclair have focused on its position in the...

Apple Hospitality REIT (NYSE:APLE) announced the resignation of Board member Kristian Gathright after seven years of service. During 2025, the company shifted 13 Marriott managed hotels to third party franchises and completed the sale of seven hotels. Apple Hospitality REIT also initiated share repurchases and continued investing in property development during 2025. Apple Hospitality REIT, trading at $12.15, has mixed longer term share performance, with a 5 year return of 13.3%, a 1 year...

If you are trying to work out whether OneStream is attractively priced or not, this article will walk through what its current valuation might be telling you. With the share price at US$23.48 and returns of 0.4% over 7 days, a 0.6% decline over 30 days and 32.5% year to date, OneStream has caught the eye of investors who are watching how sentiment could be shifting. Recent coverage has focused on OneStream as part of the broader conversation around software names, which helps explain why...

Enova International (NYSE:ENVA) announces an agreement to acquire Grasshopper Bancorp, Inc. The transaction adds a digital bank platform to Enova's existing fintech and online lending operations. The deal is expected to expand Enova's reach with small business and digitally focused customers. For investors, this move connects Enova International's consumer and small business lending focus with a full digital banking platform at Grasshopper Bancorp, Inc. NYSE:ENVA is already rooted in online...

FDA milestones put Larimar Therapeutics (LRMR) and nomlabofusp in sharper focus Larimar Therapeutics (LRMR) is back on investors’ radar after the FDA granted Breakthrough Therapy Designation to its Friedreich's ataxia candidate nomlabofusp and signaled openness to a surrogate endpoint supporting a potential accelerated approval filing. See our latest analysis for Larimar Therapeutics. The FDA update has arrived alongside a sharp pickup in momentum, with a 1 day share price return of 31.32%...

If you are wondering whether Veracyte shares are attractively priced right now, you are not alone. This article is built to help you think clearly about what you are paying for. The stock closed at US$35.69, with returns of a 0.9% decline over 7 days, a 15.6% decline over 30 days, a 15.8% decline year to date and a 6.7% decline over 1 year, while the 3 year return sits at 45.0% and the 5 year return at a 42.6% decline. Recent news coverage has focused on Veracyte's position in genomic...

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...

Lindsay (NYSE:LNN) has introduced two new safety products, the Road Runner Truck-Mounted Attenuator and the AlphaGuard Channelizing Device. The products expand the company’s roadway and work zone safety lineup, targeting construction and traffic management applications. Both launches focus on work zone protection, operational efficiency, and evolving infrastructure management needs. Lindsay, trading at $135.74, is building on its position in roadway and infrastructure safety with these new...

If you are wondering whether PicS is attractively priced at its recent levels, this article will walk through what the current numbers are really saying about the stock. The share price recently closed at US$16.81, with a 7 day return of 27.4% and a year to date return of an 11.5% decline. This has caught the attention of investors who are considering the balance between growth potential and risk. Recent news coverage around PicS has focused on its positioning within the diversified...

Pamela Seymon and former CEO Sharmistha Dubey plan to leave Match Group's Board at the 2026 Annual Meeting. The departures will change the board composition at NasdaqGS:MTCH and affect its governance structure. Investors are watching for how these board changes may influence oversight and long term company direction. Match Group, the parent of several online dating platforms, sits at the center of how people form relationships through digital services. As user behavior, regulation, and...

Select Medical Holdings (NYSE:SEM) has received a nonbinding indication of interest to take the company private. A special committee of the Board is currently reviewing the proposal. The approach represents a potential change in ownership structure and corporate control. For shareholders, the timing of this approach comes after a mixed share price record. The stock closed at $14.82, with a 1-year return of a 21.3% decline and a 3-year return of a 6.6% decline. Over 5 years, the share price...

Harmonic has agreed to sell its Video business to MediaKind, repositioning itself as a pure-play broadband company. The company is integrating its broadband technology with ATX Networks to support cable operators upgrading their networks. A multi-year agreement with izzi in Mexico targets large scale fiber expansion using Harmonic solutions. Harmonic, ticker NasdaqGS:HLIT, is refocusing around broadband at a time when its shares trade at $10.44. The stock shows mixed longer term...

Empire State Realty Trust reported fourth-quarter 2025 results with higher revenue and net income, renewed and expanded major Manhattan leases with tenants including Burlington, TJ Maxx, JP Morgan Chase, and Nespresso, and completed a US$6,000,000 share repurchase program that retired 891,530 shares. In February 2026, the company reinforced its income profile with first-quarter 2026 common and preferred dividends and highlighted a fully New York City-focused portfolio and award-winning...